Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: Development and validation of clinical predictors
Teitsma XM et al. Ann Rheum Dis 2018. doi: 10.1136/annrheumdis-2018-213035
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.